Current understanding of the cardiotoxicity-related treatment of immune checkpoint inhibitors in breast cancer
<p>Immune Checkpoint Inhibitors (ICIs) as the most important and widely used currently, have changed the traditional approach to cancer treatment and significantly improved the prognosis of most patients with advanced malignancies. Breast cancer is the most dangerous threatening tumor to women...
Saved in:
Main Author: | Jiajing Dai (Author) |
---|---|
Format: | Book |
Published: |
International Journal of Immunotherapy and Cancer Research - Peertechz Publications,
2023-05-03.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune Checkpoint Inhibitors New Insights and Recent Progress
Published: (2023) -
Immune Checkpoint Molecules and Cancer Immunotherapy
by: Alexandr V. Bazhin
Published: (2019) -
MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer
by: Julius Strauss
Published: (2017) -
Mechanistic basis for Cancer Immune Evasion and role of immune checkpoint blockades in Immuno-Oncology
by: Benjamin A Babalola, et al.
Published: (2021) -
Cardiotoxicity of Oncologic Treatments
Published: (2012)